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During a methadone maintenance treatment (MMT) for opioid 
addiction, in particular in the fi nal stage, patients may be exposed 
to stress situations. Stressful life events often need adaptive 
responses by the patients that challenge existing coping skills, in 
particular when situations are considered harmful, threatening or 
challenging.
Two signifi cant contributions in psychology related to 
coping-stress are particularly relevant to this study: Lazarus and 
Folkman (1986) stated that coping can infl uence the frequency, 
severity, duration and form of neurochemical reactions to stress, 
understanding that the coping method refl ects people’s ability 
to manage a situation and depending on the resources they have 
available, their skills to use them and the limitations hindering 
the use of these resources. Ribes (2008) expressed that biological 
modulation by contingencies is one of the psychological health 
model process factors and explains that, in the same way as 
biological functions can regulate the behavior of an individual, 
behavior can modulate the biological reaction in stressful 
situations. Lazarus and Folkman and Ribes related the behavior 
that modulates biological reactivity with the effective competences 
available and the functional capacity deployed in the organism-
environment interaction. Also from both viewpoints (cognitive-
behavioral and interbehavioral), it has been thought that the way 
in which persons behave in stressful situations can affect their 
vulnerability state and consequently, their health.
Stress is a well-known risk factor in the development of 
addiction and relapse vulnerability induced by stress is even more 
relevant than drug-cue induced relapse (Hyman, Paliwal, & Sinha, 
2007; Leri, Tremblay, Sorge, & Stewart, 2004), so in stressful 
situations, the lack of effective coping can lead detoxifi ed and 
drug-abstinent patients to experience a compulsive drug-seeking 
state. Furthermore, stress is associated with anxiety, depression, 
irritability, fear, etc. (Goeders, 2004; Sinha, 2001), as well as with 
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Abstract Resumen
Background: Stress is a known risk factor in addiction relapse, and 
prior studies show that relapse induced by stress may be more likely than 
drug-cue induced relapse. The main goal of our research was to establish 
the infl uence of perceived stress in methadone withdrawal outcome and 
the psychological factors involved. Method: A sample of 81 methadone 
maintenance treatment outpatients was evaluated and then observed 
during methadone dose reduction. Results: a multivariate analysis fi rst 
showed that successful detoxifi cation was predicted by perceived stress, 
patient-clinic staff agreement, pharmacotherapy support and social care; 
and second, perceived stress was predicted by anxiety, depression, self-
control, social care and benzodiazepine use. Conclusions: These fi ndings 
suggest that high levels of stress could increase the risk of failure in 
methadone detoxifi cation, so a clinical intervention on the psychological 
factors related to stress would be indicated to improve effectiveness of 
methadone withdrawal treatment.
Keywords: Methadone, detoxifi cation, stress, self-control, social support.
Estrés percibido relacionado con la retirada de metadona. 
Antecedentes: el estrés es un conocido factor de riesgo de recaída de 
la adicción y estudios anteriores muestran que puede ser mayor la 
probabilidad de recaída ante respuestas de estrés que ante estímulos 
asociados al consumo de drogas. El objetivo de nuestra investigación fue 
averiguar la infl uencia del estrés percibido en el resultado de la retirada 
de metadona y su relación con los procesos psicológicos implicados. 
Método: 81 pacientes ambulatorios en tratamiento de mantenimiento 
con metadona fueron evaluados y posteriormente observados durante la 
reducción de dosis de metadona. Resultados: el análisis multivariante 
mostró en primer lugar, como predictores del éxito de la desintoxicación, 
al grupo compuesto por estrés percibido, acuerdo paciente-facultativos, 
tratamientos farmacológicos complementarios y atención social; en 
segundo lugar, como predictores del estrés percibido, al conjunto de 
factores de ansiedad, depresión, autocontrol, apoyo social y consumo de 
benzodiacepinas. Conclusiones: los resultados sugieren que niveles altos 
de estrés podrían incrementar el riesgo de fracaso en la desintoxicación, 
por lo que una intervención clínica sobre los procesos psicológicos 
relacionados con el estrés resultaría indicada para mejorar la efectividad 
del tratamiento de retirada de metadona.
Palabras clave: metadona, desintoxicación, estrés, autocontrol, apoyo 
social.
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psychological responses related to Grade I methadone withdrawal 
symptoms that can even continue for a long time after achieving 
zero-dose (Kanof, Aronson, & Ness, 1993; Wermuth & Brummet, 
1987). Therefore, methadone withdrawal itself involves a situation 
with a high probability of experiencing stress for patients ending a 
maintenance treatment. Besides, when the zero-dose of methadone 
is achieved after a long—sometimes very long—maintenance 
period, demand level and adaptation diffi culties are increased in 
patients who have managed to overcome the detoxifi cation barrier. 
Milby et al. (1994) referred to this as “detoxifi cation phobia”, 
an emotional disorder that may be a predictor of discontinuing 
methadone withdrawal, associated on the one hand, with the 
occurrence of withdrawal symptoms during dose reduction and, 
on the other hand, with posttreatment relapses due to patients’ 
mistrust of their own ability to maintain drug abstinence. These 
authors’ conclusions are consistent with the fi ndings of Reilly et 
al. (1995) in a study on perceived self-effi cacy in patients during 
methadone maintenance treatment following a detoxifi cation 
protocol. These authors defi ned self-effi cacy as people’s 
confi dence in their own skills to prevent opioid consumption in 
risk situations. They measured self-effi cacy during maintenance 
treatment and during methadone reduction. Results indicated that 
the self-effi cacy level increased progressively from the start of the 
maintenance treatment and continued along the stabilization phase 
until the start of the methadone dose reduction, when self-effi cacy 
level decreased to that of the fi rst months of dose stabilization. 
The above studies suggest that some stress-associated factors, 
such as affective states and/or the competence level of patients 
on MMT may be present in the methadone detoxifi cation process 
when patients are undergoing such interventions. The main goal of 
our study was to establish whether this relationship can be found in 
Spanish population, in opioid-dependent patients on MMT before 
starting methadone withdrawal, as well as whether some stress 
predictors could be established that allowed for future planning 
of adequate psychotherapeutic procedures that would contribute 
to the success of detoxifi cation and lasting abstinence during 
posttreatment. Based on clinical experience, we expected that, in 
addition to emotional and competence factors, other psychological 
variables, such as drug abuse, use of benzodiazepines and a 
non-socially adjusted lifestyle, would be also related to a higher 
perception of stress in patients starting the methadone withdrawal 
process.
Method
Participants
Eighty-one outpatients from 16 clinics from the Region of 
Madrid participated in a cohort study performed between 2007 
and 2009. The mean age was 41.76 years (SD = 6.35; range: 27.51 
- 60.69), distributed as follows: 74.1% men and 26.9% women; 
49.4% were single and 30.8% married or with a partner; 44.4% 
lived with their family of origin and 27.2% with their own family; 
29.6% had primary education, 35.8% secondary education, and 
23.5% high school or an equivalent education; 48.2% of the 
participants were employed, 27.2% were unemployed at that time, 
and 16% received work disability; 80.2% had no legal incidents 
when the study was started. Clinically, 56.8% of the patients had 
positive markers for HCV, 27.2% for HIV and 13.6% for HBV; 
16% of them had no biological diseases, and 18.5% had been 
diagnosed with dual pathology; 39.4% followed some type of 
drug therapy due to biomedical conditions and, with regard to 
psychoactive drugs, 38.3% were treated with benzodiazepines, 
16% with antidepressants, 4.9% with antipsychotics, and 1.2% 
with anticonvulsants. The mean age at onset of heroin use was 
around 20.3 years (SD = 5.21; range: 11 - 35) and the mean 
addiction time 17.68 years (SD = 5.84; range: 2.32 - 32.10). The 
participants reported abstinence from heroin (73.4%), and cocaine 
(65.8%) during the 6 months prior to inclusion in the study, and 
from cannabis (62%) and alcohol (37.7%) during the previous 3 
months.
Instruments 
– Questionnaire adapted from Carreras (2007) to inquire 
about social, demographic and clinic variables, drug abuse 
and characteristics of methadone maintenance treatment. 
– Perceived Stress Scale (short version) (PSS-10; Cohen, 
Kamark, & Mermelstein, 1983). This instrument evaluates 
the level of perceived stress during the last month. The 
10-item version provides a reliable and valid measure of 
perceived stress for use where a short scale is required 
(Remor, 2006). The questionnaire consists of 10 items with 
a 5-point response scale ranging from 0 (never) to 4 (very 
often). The total score of the PSS-10 is obtained by reversing 
the scores of Items 4, 5, 6 and 7 and subsequently adding the 
10 items’ scores. A higher score indicates a higher level of 
perceived stress. Cronbach’s alpha coeffi cient for the PSS-
10 in the current sample was .88.
– Hospital Anxiety and Depression Scale (HADS; Zigmond 
& Snaith, 1983). This scale is composed of 14 items divided 
into two subscales with 7 items each, evaluating Anxiety 
(HADS-A) and Depression (HADS-D), respectively. The 
scale is a self-administered instrument with a 4-point 
Likert-type scale (0 to 3). Some items (1, 3, 5, 6, 8, 10, 11, 
and 13) scores need reversing. Cronbach’s alpha coeffi cient 
for the HADS-A in the current sample was .81 and .86 for 
the HADS-D.
– Oviedo Sleep Questionnaire (OSQ; Bobes et al., 2000). This 
is a brief semistructured interview for performing the DSM-
IV and ED-10 diagnoses of insomnia and hypersomnia. 
For this study, we used only the insomnia subscale of the 
instrument, composed of 9 items in a 5-points scale (1 to 5; 
range: 9 - 45). Cronbach’s alpha coeffi cient for the insomnia 
subscale in the current sample was .88.
– Psychosocial Interaction Variables Questionnaire (PIV; 
Pedrero, Pérez-López, De Enea, & Garrido, 2005). This 
was designed to assess competences and was validated in 
Spanish drug-addicted population. It is composed of 84 
items with a 4-point response scale ranging from 1 (strongly 
agree) to 4 (strongly disagree). The items are divided into 
nine subscales: Self-control (11), Self-effi cacy (9), Problem-
focused coping (11), Emotion-focused coping (recoded to 
make its sign equivalent to the other skill variables) (12), 
Social support (5), Social skills (10), Locus of control (3), 
Optimism (11) and Self-concept (12). Partial scores of the 
PIV subscales are obtained by tabulating items to + 2, + 
1, -1, -2. Items left blank or double-marks are scored with 
0. A higher score indicates a higher level of competences. 
Cronbach’s alpha coeffi cient for the total PIV in the current 
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sample was .94 and the subscales ranged from .72 (locus of 
control) to .83 (Self-concept).
– Data from the clinical histories about the evolution of 
patients on MMT and during the dose reduction process were 
entered in the report of each patient with their consent.
Procedure
The sample was selected from a reference population of 2,710 
patients on MMT who were undergoing withdrawal treatment 
from the start of the study and who according to the inclusion 
criteria, were adult men and women with a diagnosis of opioid 
dependence. Patients undergoing methadone detoxifi cation on 
an urgent basis or for some type of administrative penalty were 
excluded; detoxifi cation procedures shorter than one month 
were not considered either. As a result, the target population was 
composed of 148 patients. For this study only the 89 patients who 
previously signed informed consent and completed assessment 
instruments were selected. After excluding the cases with missing 
responses, 81 participants composed the fi nal sample.
The 81 participants were included in to the study by order 
of arrival at each respective site, as the starting condition 
of methadone detoxifi cation occurred. The detoxifi cation 
procedure used in all cases was the gradual dose reduction, with 
pharmacotherapy support in 28% of cases, mainly symptomatic 
therapy (benzodiazepines and antidepressants) and alcohol 
interdictors (disulfi ram). The average dose of methadone at the 
beginning of detoxifi cation was 55.58 mg. (SD = 38.15; range: 11 
- 230). The occurrence of other procedures during detoxifi cation 
was also registered, such as individual psychotherapy, which took 
place in 43.5% of cases and/or social care, in 33%. The particular 
characteristics of the psychotherapeutic treatment undertaken and 
the specifi cs of social care were not recorded for this study.
Having achieved the goal of zero-dose, 43.80% of the 
participants continued in conventional drug-free treatments; 47% 
did not follow specifi c treatments but underwent a MMT follow-
up ranging from one to six months; the remaining 9.20% were lost 
to follow-up.
The observation period for each patient ranged from the 
inclusion in the study to discontinuation, either by relapse during 
detoxifi cation or by reaching the zero-dose, the latter considered in 
this study as the success criterion. The main detoxifi cation time in 
relapsed participants was 428.21 days (SE = 52.63; 95% CI: 325.06 - 
531.37). In patients who managed to reach zero-dose of methadone, 
it was 469.81 days (SE = 52.76, 95% CI [573.23, 366.40]. Patients 
observed after achieving zero-dose were able to maintain abstinence 
for an average of 516.24 days (SE = 60.43; 95% CI [397.80, 634.68], 
and the greatest impact of relapses took place between 20 and 24 
months after reaching zero-dose of methadone.
Data analysis
Descriptive data. The arithmetic means, standard deviations 
and relative and absolute frequencies were calculated for variables 
related to the personal characteristics of the participants, the 
methadone maintenance treatment conditions they had followed 
at their respective sites and the evolution of methadone withdrawal 
treatment they had underwent. Finally, descriptive data were 
obtained from methadone withdrawal outcomes, in terms of 
reaching zero-dose and posttreatment evolution.
Survival analysis. This procedure was used to estimate 
the participation time period of patients in the study at the two 
observed moments: achieving zero-dose of methadone and 
abstinence during posttreatment. Each participant was followed-
up for a certain period of time (which was different for each case), 
from the initial event (starting dose of methadone reduction) until 
the terminal event (detoxifi cation interruption or relapse after 
zero-dose) or until the end of the study. The monitoring period 
ended when a terminal event was shown by the participants. One 
terminal event in each analysis was considered. As a result, three 
analyses were performed considering three possible terminal 
events: zero-dose, detoxifi cation interruption and relapse during 
posttreatment.
Multivariate analysis. In the inferential level of analysis, a 
logistic regression model was fi rst built to establish the predictors 
of success in reaching zero-dose of methadone. The variables 
that were signifi cant according to a previous bivariate analysis 
were entered in the model. A second linear regression procedure 
was applied to investigate more precisely the perceived stress 
predictors, starting from different psychological variables related 
signifi cantly to this factor. The variables that had exceeded the cut-
off point (p ≤ .15) were entered in the multiple regression equation 
by the forward entry method. The analyses were performed with 
the software SPSS-18.0.
Results
Methadone withdrawal treatment outcomes
Fifty-eight percent of the patients undergoing methadone 
withdrawal treatment discontinued the process before achieving 
zero-dose and 11% had a relapse in the months following 
detoxifi cation. However, 28% of the study participants had a 
successful detoxifi cation and were able to remain abstinent for 
up to six months after methadone withdrawal; 3% of the patients 
could not be observed during the posttreatment period.
Factors associated with zero-dose of methadone
Bivariate analysis showed a successful detoxifi cation relationship 
with anxiety (t = 2.10, p = .04, d = -.49), perceived stress (t = 3.20, 
p = .002, d = -.75), MMT permanence (t = 3.30, p = .001, d = -.73), 
initial dose reduction (t = 2.11, p = .04, d = -.49), opioid withdrawal 
symptoms (t = -2.63, p = .01, d = .62), psychological management 
(χ2 = 5.55, p = .02), employment counseling service (χ2 = 4.23, p 
= .04), frequency of employment counseling service (χ2 = 7.31, p 
= .03), detoxifi cation treatment compliance (χ2 = 8.79, p = .003), 
interdisciplinary assessment (χ2 = 5.36, p = .02), patient-clinic 
staff agreement (χ2 = 10.02, p = .002), pharmacotherapy support 
(χ2 = 11.94, p = .001), social care (χ2 = 6.98, p = .008), heroin use 
(χ2 =5.63, p = .02), and cocaine use (χ2 =10.06, p = .002). 
Predictors of zero-dose of methadone
The inferential data analysis allowed relating the methadone 
withdrawal outcome in detoxifi cation stage (zero-dose as dependent 
variable) with the other variables examined. The posttreatment 
evolution could not be analyzed due to reduced sample size of 
patients with successful detoxifi cation. The fi nal equation, 
containing the next set of four variables: pharmacotherapy 
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support (OR = 23.81, p = .001), social care (OR = 12.89, p = .002), 
patient-clinic staff agreement (OR = 12.29, p = .02) and perceived 
stress (OR = .87, p = .005), accounted for 59% of the variance 
on methadone zero-dose achievement (R2 = .59). The fi rst three 
variables appeared as protection factors, and stress as a risk factor 
for the success of detoxifi cation. Predictive validity of the four-
variable model was supported by sensitivity and specifi city (Se = 
85.8%, Sp = 78.1%) and the ROC curve (AUC= .90, 95% CI: .82 - 
.97), offering a 90% power of prediction according to participants’ 
achievement of zero-dose. This model complied with the criteria 
of normality, linearity, no co-linearity and sample size.
Factors associated with perceived stress
A fi rst simple linear regression analysis showed the relationship 
of perceived stress as a dependent variable related to personal 
variables with the affective states of anxiety, depression and 
insomnia; with the competences of self-effi cacy, self-control, 
self-concept, optimism, social skills, problem-focused coping, 
emotion-focused coping and social support; with heroin, cocaine 
and benzodiazepine use (prescribed and/or self-administered); 
and with lifestyle (consisting of living in family, having an 
employment, having no current legal incidents, and heroin and 
cocaine abstinence in the past 6 and 3 months, respectively). The 
coeffi cients and signifi cance tests are shown in Table 1. 
Predictors of perceived stress
Upon constructing a multiple linear regression model from 
all these variables, the equation was obtained formed by the 
group: anxiety, depression, self-control, social support and use 
of benzodiazepines, as better predictors of perceived stress. 
The model coeffi cients, standard errors, signifi cance tests and 
confi dence intervals are included in Table 2.
Findings showed a higher level of perceived stress when higher 
scores in anxiety and depression HAD subscales were obtained by 
patients. Self-control and social support had an inverse relationship 
with perceived stress, indicating that high levels of these 
competences reduced the stress level perceived by the patients. 
Finally, the model indicated that patients using benzodiazepines 
before undergoing methadone reduction had a higher perceived 
stress level than patients without this psychoactive drug use. 
The fi ve-predictor model accounted for 72% of the variance 
of perceived stress (R2 = .72) and complied with the criteria of 
normality (K-S: p = .20; S-W: p = .12), linearity, sample size, no 
co-linearity, homogeneity and independence. 
Discussion
Psychological factors related to methadone withdrawal in 
MMT outpatients indicated perceived stress as one of predictors 
for reaching zero-dose, a relationship with no empirical evidence 
to date. Regarding to affective states, an association had been 
previously established with anxiety, depression and post-traumatic 
stress (Latowsky, 1996; Milby et al., 1994), with the so-called 
“detoxifi cation phobia” (Gentile & Milby, 1992) and with the 
organic mood syndrome or post-methadone syndrome (Kanof et 
al., 1993; Wermuth & Brummet., 1987). Also, in line with other 
international studies, the effi cacy of the intervention was related 
to patient-clinic staff agreement, pharmacotherapy support 
and social care during dose reduction (Cushman, 1981; Gentile 
& Milby, 1992; Kanof et al., 1993; Stimmel & Rabin, 1974; 
Tennant & Shannon, 1978; Wermuth & Brummet, 1987). This 
fi nding opens up a new insight for our research, under the clinical 
utility of knowing empirically the factors linked to stress and 
thus improving the psychological conditions of patients entering 
methadone withdrawal treatment.
The hypothesis of our study considered that affective states, 
competences, heroin, cocaine or benzodiazepine use and lifestyle 
could be related to perceived stress. The results of simple 
regression analysis confi rmed the global nature of this hypothesis. 
The use of cannabis and alcohol did not reach statistical 
signifi cance, but heroin, cocaine and benzodiazepine use did. 
Also the lifestyle acquired during the maintenance treatment 
had a signifi cant relationship with the stress level of the patients’ 
coping with methadone withdrawal. All these factors could be 
used to establish, via multivariate statistical procedures, the set of 
psychological factors with a higher capacity to predict perceived 
Table 1
Simple linear regression analysis. Dependent variable: perceived stress.
Cut-off point, p≤0.15
Variables B t p
95% confi dence
interval for B
Anxiety 1.85 9.17 .00 1.46 to 2.27
Depression 1.28 7.96 .00 .92 to 1.53
Insomnia .41 4.26 .00 .22 to 0.60
Self-concept -.12 -5.08 .00 -.17 to -0.07
Self-effi cacy -.11 -3.55 .001 -.18 to -0.05
Optimism -.13 -4.67 .00 -.18 to -0.07
Locus Control -.02 -1.15 .26 -.06 to 0.02
Social skills -.06 -2.17 .03 -.11 to -0.00
Emotion coping -.12 -4.99 .00 -.17 to -0.07
Problem coping -.15 -4.57 .00 -.21 to -0.08
Social support -.04 -2.02 .05 -.08 to -0.00
Self-control -.17 -7.60 .00 -.22 to -0.13
Use of heroin 3.40 1.67 .10 -.65 to 7.46
Use of cocaine 4.03 2.13 .04 .26 to 7.80
Use of cannabis .82 .43 .67 -2.98 to 4.62
Alcohol intake -1.72 -.89 .38 -5.58 to 2.14
Benzodiazepine use 6.66 3.79 .00 3.16 to 10.16
Lifestyle -1.98 -2.89 .005 -3.34 to -0.62
Table 2
Multiple linear regression model. Dependent variable: perceived stress
 Predictors
Non-
standardized 
coeffi cients  
Standardized 
coeffi cients
95% confi dence 
interval for B
 B SE B β t p
Lower
 limit
Upper 
limit
(Constant) 6.54 1.74 3.75 .00 3.06 10.02
Anxiety .79 .23 .31 3.42 .001 .33 1.25
Depression .45 .17 .24 2.62 .01 .11 .78
Self-control -.08 .02 -.32 -3.92 .00 -.13 -.04
Social support -.04 .01 -.19 -3.01 .004 -.06 -.01
Benzodiazepine use 4.15 1.10 .24 3.79 .00 1.97 6.34
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stress, and the result was the group formed by anxiety, depression, 
self-control, social support and use of benzodiazepines; the fi rst 
two indicated a direct relationship with stress and the next two 
an inverse relationship; benzodiazepine use, also had a direct 
relationship with stress. Therefore, greater emotional disorder and 
lower competence level, higher stress level results; psychoactive 
drugs like benzodiazepines should not be indicated, at least 
exclusively, whereas psychological procedures ought to be used in 
order to reduce and control perceived stress level.
Several studies on addiction processes have shown the 
relationship of stress with anxiety and depression disorders, 
including post-traumatic stress disorder and increased risk of 
substance abuse disorder (Leri et al., 2004; Liao et al., 2011; 
Sinha, 2001). And some studies based on psychological models 
have related perceived stress to coping skills. According to 
several authors, drug-cue repeated exposure can induce craving 
and increase the risk of relapse (Goeders, 2004; Hyman et al., 
2007; Hyman et al., 2009; Sinha, 2008; Turner & Lloyd, 2003). 
Hyman and colleagues (2007) found differences between stress-
induced relapse and drug-cue-induced relapse. In the fi rst 
case, drug craving was associated with high levels of anxiety, 
fear and sadness, whereas for drug-cue induced craving, this 
increase of negative emotions did not occur. These authors 
subsequently observed that opioid-dependent individuals 
treated with antagonists had higher levels of stress and used 
less adaptive coping strategies than the control group to which 
they were compared. Their fi ndings showed that several factors 
were associated with perceived stress: problem-focused coping, 
emotion-focused coping, maladaptive avoidance coping and 
social support; and they established the predictive value of two 
of them: maladaptive avoidance coping and social support. These 
results are similar to those of our study.
Relationship with stress has been also investigated in relation to 
other competences such as self-control. In a review with adolescent 
population, Sinha (2008) highlighted that acute emotional stress 
was associated with low control of impulses, inability to inhibit 
inappropriate behaviors and to delay reinforcement, which 
involved a risk factor for substance abuse and other maladaptive 
behaviors in this population. Ladero, Orejudo, and Carrobles 
(2005), reported that self-effi cacy and social support were related 
to compliance with anti-retroviral treatments in drug-dependent 
population on MMT.
Finally, our results indicated that benzodiazepine use increased 
stress perception. Recent studies have reported the risk of using 
benzodiazepines in patients on MMT, highlighting the high 
prevalence of abuse risk markers in this population (Carreras, 
2007), mentioning the effect of withdrawal on sleep regulation 
and its relationship with chronic pain, high doses of methadone 
and psychiatric disorders (Peles, Schreiber, & Adelson, 2005), 
or considering that benzodiazepine prescription misuse in this 
population can increase the risk of overdose and relapse in patients 
discontinuing opioid use (Chen et al., 2011).
The conclusions of this study therefore support considering that 
psychological factors related to perceived stress can contribute 
to planning an interdisciplinary intervention in methadone 
maintenance treatments. This is particularly so in the fi nal stage, 
but also throughout the therapeutic process if it is intended to 
promote a change in lifestyle and generate competences that 
increase the probability of social adjustment and lasting drug 
abstinence. 
This study is not without limitations. First, it shares a common 
limitation of this kind of studies related to small sample sizes. 
Sample size was acceptable for the detoxifi cation phase analysis, 
but was notably reduced during posttreatment. Thus, these results 
should be taken with caution and should be further examined 
in the future using larger samples. Another limitation stemmed 
from the diffi culties in measuring competences. While the PIV 
questionnaire has been used in drug-dependent individuals, it 
has not been used in previous similar studies and it is therefore 
necessary to be cautious when comparing fi ndings.
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